TABLE 4.
Intervention features of included studies for secondary prophylaxis
| Author (reference) | Endoscopic band ligation sessions, n (mean) |
Variceal |
Pharmacological, dose, mg (mean) |
||
|---|---|---|---|---|---|
| Obliteration, % | Recurrence, % | Beta-blocker | ISMN | ||
| Ahmad et al (24) | 3.5 | – | – | Propranolol; 50 | 33 |
| Lo et al (25) | 3.3 | 66.67 | 43.33 | Nadolol; 48 | 30 |
| Romero et al (26) | 3.4 | 69.23 | – | Nadolol; 88 | 57.7 |
| Sarin et al (27) | 3 | – | – | Propranolol; 12.4 | 34.2 |
| Patch et al (28) | 2 | – | 25.64 | Propranolol; 80 | 10–20 |
| Villanueva et al (29) | – | – | – | Nadolol; 96 | 66 |
ISMN Isosorbide mononitrate